Crinone vaginal gel 8%, 1.45g x 15 applicators — Made in Great Britain — Free Delivery

Product description 

Crinone gel vaginal 8% is indicated for:

• Treatment of infertility caused by luteal phase deficiency;
• Treatment of infertility within IVF procedures (in vitro fertilization): in patients with normal ovulatory cycles, in which infertility is associated with tubal disease, endometriosis or idiopathic pathologies.

Compound

Active ingredient: progesterone;

1 applicator (1.125 g of gel available for injection) contains 90 mg of progesterone (8% w/w);

Excipients: glycerin, mineral lung oil, hydrogenated palm oil glycerides, carbomer 974R, sorbic acid, polycarbophil, sodium hydroxide, purified water.

Contraindications

• Hypersensitivity to the active substance or to any excipient of the preparation;
• Uterine bleeding of unknown etiology;
• Known or suspected malignant tumors of the mammary glands or genital organs;
• Porfiria;
• Thrombophlebitis, thromboembolic disorders, acute disorders of cerebral circulation - existing or in history;
• A miscarriage that didn't happen.

Mode of application

Treatment of infertility caused by luteal phase deficiency. After the established ovulation or alternatively on the 18th-21st day of the cycle, the contents of 1 applicator (1.125 g of 8% gel) are administered daily.

When used as part of IVF procedures. After laboratory confirmation of pregnancy, the contents of 1 applicator (1.125 g of 8% gel) are administered daily for 30 days.

The preparation is intended for single vaginal administration. The preparation that remains in the applicator after administration must be destroyed.

Application features

pregnant

Not recommended.

Children

Cannot be used by children.

Drivers

There have been cases of the development of drowsiness, patients who drive transport work with complex mechanisms should refrain from this type of activity.

Overdose

Overdose cases are not expected, since each dose is administered using a separate disposable applicator. However, in case of an overdose, the preparation should be discontinued and symptomatic treatment should be started.

Side effects

General disorders and reactions at the injection site. Often: headache, pain in the perineum or joints, memory impairment, weakness, pain, vaginal itching and other mild local reactions.

Interaction

Although cases of interaction with other preparations have not been reported, Krinon® should not be used simultaneously with other preparations intended for vaginal administration.

Storage conditions

Store at a temperature not exceeding 25°C. Do not freeze.

Keep out of the reach of children.

Do not use after the expiry date stated on the package.

Shelf life - 3 years.